Brief: China Resources Pharmaceutical Posts Qtrly Results For China Resources Boya Bio-Pharmaceutical
April 25 (Reuters) - China Resources Boya Bio pharmaceutical Group Co Ltd 300294.SZ: QTRLY NET PROFIT FOR CHINA RESOURCES BOYA BIO-PHARMACEUTICAL RMB139.3 MILLION QTRLY REVENUE RMB535.9 MILLION FOR CR BOYA BIO-PHARMACEUTICAL Further company coverage: 300294.SZ ((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Resources Pharmaceutical
See all newsBrief: China Resources Pharmaceutical Group Declares Interim Dividend Of RMB0.087 Per Share
Brief: China Resources Pharmaceutical Says Tasly Pharmaceutical Posts HY Net Profit Attributable Of RMB 892.7 MLN
Brief: China Resources Pharmaceutical Group Says HY Revenue RMB 1.93 Billion For CR Jiangzhong
Brief: China Resources Pharmaceutical Group Posts HY Revenue RMB 1.64 Billion, Down 50.97% For KPC Pharmaceuticals
Brief: China Resources Pharmaceutical Says CR Boya Bio-Pharmaceutical Posts Quarterly Unaudited Revenue RMB 321.1 Million, Net Profit RMB 30.0 Million